Cogstate Ltd (AU:CGS) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Cogstate Ltd has announced a partnership with Medidata to deliver a unified solution for central nervous system disease assessments, marking a significant strategic expansion for the company. This collaboration is expected to boost Cogstate’s sales, with the first contract anticipated soon. Additionally, Cogstate’s recent financial performance shows promising growth, supported by a new share buyback initiative.
For further insights into AU:CGS stock, check out TipRanks’ Stock Analysis page.
